![Ruo Yu Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruo Yu Chen
Director/Board Member at
Continent Pharmaceutical Inc.
Net worth: - $ as of 2026-05-30
Profile
Ruo Yu Chen currently works at Continent Pharmaceutical, Inc., as Executive Director from 2018, Beijing Continent Pharmaceutical Co., Ltd., as Executive Director from 2018, GNI-EPS Pharmaceuticals, inc., as Supervisor, Cullgen, Inc., as Finance Controller, and Cullgen Shanghai, Inc., as Supervisor.
Ms. Chen also formerly worked at GNI Group Ltd., as Director-Finance & Accounting from 2014 to 2021, GNI USA, Inc., as Senior Vice President-Finance, Protiviti LLC, as Manager-Internal Audit Division from 2011 to 2014, and Gyre Therapeutics, Inc., as Chief Financial Officer from 2023 to 2026.
Ms. Chen received her undergraduate degree in 1992 from Nankai University and graduate degree from Graduate School of Economics Kyoto University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Ruo Yu Chen active positions
| Companies | Position | Start |
|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Director/Board Member | 2018-07-17 |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Comptroller/Controller/Auditor | - |
Cullgen Shanghai, Inc. | Director/Board Member | - |
GNI-EPS Pharmaceuticals, inc. | Director/Board Member | - |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells biological technology medicines | Director/Board Member | 2017-12-31 |
Former positions of Ruo Yu Chen
| Companies | Position | End |
|---|---|---|
| GNI GROUP LTD. | Comptroller/Controller/Auditor | 2020-12-31 |
Protiviti LLC
 Protiviti LLC Miscellaneous Commercial ServicesCommercial Services Provides independent risk consulting and internal audit services | Comptroller/Controller/Auditor | 2013-12-31 |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Corporate Officer/Principal | - |
Training of Ruo Yu Chen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GNI Group Ltd.
 GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products | Health Technology |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Health Technology |
GNI-EPS Pharmaceuticals, inc. | |
GNI USA, Inc.
GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
Graduate School of Economics Kyoto University
 Graduate School of Economics Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protiviti LLC
Protiviti LLC Miscellaneous Commercial ServicesCommercial Services Provides independent risk consulting and internal audit services | Commercial Services |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells biological technology medicines | Health Technology |
Cullgen Shanghai, Inc. |
- Stock Market
- Insiders
- Ruo Yu Chen
